Willow Biosciences Inc. WLLW Archives - Page 2 of 3

WednesdayDec 04, 2019 9:38 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Commence Trading on the Toronto Stock Exchange on December 5

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Tuesday announced its receipt of final approval to list its common shares on the Toronto Stock Exchange (the "TSX"). According to the update, Willow’s common shares will commence trading on the TSX effective as of the open of the market on Thursday, December 5, 2019. The common shares will continue to trade under the symbol "WLLW" upon listing on the TSX. In conjunction with the TSX listing, the common shares will concurrently be delisted from the Canadian Securities Exchange. To view the full press release, visit http://ibn.fm/6kylc About Willow Biosciences Inc. Willow is…

TuesdayDec 03, 2019 10:06 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Comments on DEA Descheduling Partner’s CBD

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol (“CBD”), this morning issued a release commenting on the recent news that the U.S. Drug Enforcement Agency (“DEA”) has removed Purisys, LLC’s CBD from Schedule I of the Controlled Substances Act (“CSA”). Purisys, the spin-out entity of Noramco, Inc.’s cannabinoids business, began operating as a stand-alone entity on October 1, 2019 and is expected to become independent from Noramco on January 1, 2020. Per the terms of a joint development agreement, Noramco is Willow's exclusive manufacturing and distribution partner. Willow holds…

MondayNov 25, 2019 2:09 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Receipt of Conditional Approval to List on the Toronto Stock Exchange

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced its receipt of conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares on the TSX. According to the update, final approval of the listing is subject to Willow Biosciences meeting certain TSX customary conditions, and Willow will issue a statement upon TSX’s confirmation of the commencement date. "Listing on the TSX is a significant milestone for Willow. The TSX will broaden our investment appeal and leave us well positioned to execute on our strategic initiatives for 2020 and beyond,” Willow President and Chief Executive Officer Trevor…

FridayNov 22, 2019 9:17 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Posts Q3 2019 Financial Results, Operations Update

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Thursday announced its financial and operating results for the three and nine months ended September 30, 2019. Among other highlights, the company reported that it ended the quarter with around $23.2 million of working capital and $24 million of cash on hand. Willow’s unaudited condensed consolidated interim financial statements and related management's discussion and analysis are available at www.SEDAR.com or on the company’s website. “Over the past few months, Willow has continued to advance its business strategy and achieved several important milestones,” Willow Biosciences president and chief executive officer Trevor Peters stated in…

ThursdayNov 07, 2019 10:42 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) today announced its plans to participate in the Cowen 2nd Annual Boston Cannabis Conference, a carefully curated event to represent leading-edge companies across a wide array of products, brands, technologies, services and health care providers in the emerging cannabis industry. According to the update, the event is scheduled to be held at the InterContinental Boston on November 12-13, 2019. Willow Vice President, Commercial Operations Dr. Chris Savile will be speaking on a Biosynthesis panel on November 13 at 8:50 AM ET. In addition Dr. Savile and Willow CFO Travis Doupe will be available for…

TuesdayNov 05, 2019 9:47 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Begin Trading on the OTCQB® Venture Market

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced that it has been approved to commence trading on the OTCQB® Venture Market (the "OTCQB"), under the symbol "CANSF," beginning today, November 5, 2019. The listing will enable Willow Biosciences access to a broader base of U.S. and international retail and institutional investors, ultimately providing increased data access, transparency and liquidity to investors. "Listing on the OTCQB will allow for greater engagement with our U.S. investor base,” Willow CEO Trevor Peters said in the news release. “As we move towards scale up of ultra-pure, pharmaceutical grade cannabidiol (“CBD”) with our partner…

TuesdaySep 17, 2019 10:57 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen's Park Ballroom. To view the full press release, visit http://ibn.fm/BdhG5 About Willow Biosciences Inc. Willow is a Canadian biotechnology company based in Calgary, Alberta,…

TuesdaySep 10, 2019 3:14 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in a research report by Eight Capital. Per the report, Eight Capital issued a ‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by Willow’s chosen method of cannabinoid production, biosynthesis, which holds the potential to disrupt the industry. The report also detailed upcoming catalysts for the company, including the potential formation of partnerships and agreements; quantitative milestones demonstrating increased throughput of the company’s proprietary yeast strains; planned uplisting to the Toronto Stock…

TuesdaySep 10, 2019 9:59 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Stock Option Grant and Unit Issuance

Willow Biosciences Inc. (CSE: WLLW) on Tuesday announced that it has granted an aggregate of 1,118,000 stock options for certain employees to purchase common shares of Willow pursuant to the terms and conditions of its stock option plan. According to the update, the options expire five years from the grant date, are exercisable at a price of $0.60 per common share, and vest as to one third on the grant date and on each of the first and second anniversaries of the grant date. Willow has additionally issued 21,057 units of the company in connection with its previous April 2019…

WednesdaySep 04, 2019 9:34 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Engages The Howard Group; Presenting at the 8th Annual Gateway Conference

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, on Tuesday announced its engagement of The Howard Group as its capital markets communications advisor. The engagement is for twelve months at a fee of $9,000 per month, effective August 15, 2019, and is renewable after six months. In this role, The Howard Group will assist Willow with traditional and online initiatives that target the investment community in addition to institutional and retail investing groups. The Howard Group will also provide ongoing commentary on the company’s activities through its blog (http://ibn.fm/kOruS).…

Site Search

Company Search

Tag: Willow Biosciences Inc. WLLW